Ipca Laboratories Ltd
NSE :IPCALAB BSE :524494 Sector : PharmaceuticalsBuy, Sell or Hold IPCALAB? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
13 Nov 1504.85 (-3.50%) | 12 Nov 1559.50 (1.84%) | 11 Nov 1531.30 (-1.75%) | 08 Nov 1558.65 (0.02%) | 07 Nov 1558.40 (-1.59%) | 06 Nov 1583.60 (-0.83%) | 05 Nov 1596.80 (0.72%) | 04 Nov 1585.35 (-1.35%) | 01 Nov 1607.10 (1.15%) | 31 Oct 1588.80 (1.70%) | 30 Oct 1562.20 (-1.44%) | 29 Oct 1585.10 (-0.52%) | 28 Oct 1593.45 (0.67%) | 25 Oct 1582.85 (0.12%) | 24 Oct 1580.95 (0.97%) | 23 Oct 1565.80 (-1.42%) | 22 Oct 1588.40 (-1.61%) | 21 Oct 1614.35 (-2.15%) | 18 Oct 1649.85 (0.15%) | 17 Oct 1647.30 (-0.50%) | 16 Oct 1655.65 (-2.79%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bearish
Medium Term Investors
Neutral
Long Term Investors
Bullish
Moving Averages
5 DMA
Bearish
1542.2
10 DMA
Bearish
1567.5
20 DMA
Bearish
1582.07
50 DMA
Bearish
1532.85
100 DMA
Bullish
1404.51
200 DMA
Bullish
1317.24
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Nov 13, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1625 | 1595.95 | 1525.37 | - | - |
R2 | 1595.95 | 1567.45 | 1518.53 | 1591.83 | - |
R1 | 1550.4 | 1549.85 | 1511.69 | 1542.16 | 1573.18 |
P | 1521.35 | 1521.35 | 1521.35 | 1517.23 | 1532.74 |
S1 | 1475.8 | 1492.85 | 1498.01 | 1467.56 | 1498.58 |
S2 | 1446.75 | 1475.25 | 1491.17 | 1442.63 | - |
S3 | 1401.2 | 1446.75 | 1484.34 | - | - |
Key Metrics
EPS
24.27
P/E
62.14
P/B
6.03
Dividend Yield
0.27%
Market Cap
38,179 Cr.
Face Value
1
Book Value
250.24
ROE
8.69%
EBITDA Growth
412.33 Cr.
Debt/Equity
0.24
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Ipca Laboratories Ltd Quaterly Results
Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | |
INCOME | 1630.06 | 2072.51 | 2143.77 | 2051.95 | 2113.24 |
PROFIT | 162.82 | 145.06 | 127.19 | 122.62 | 192.24 |
EPS | 6.42 | 5.72 | 7.09 | 2.35 | 7.58 |
Ipca Laboratories Ltd Quaterly Results
Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | |
INCOME | 1529.5 | 1698.81 | 1524.17 | 1525.72 | 1581.25 |
PROFIT | 166.58 | 162.13 | 136.63 | 112.74 | 204.13 |
EPS | 6.57 | 6.39 | 5.4 | 2.55 | 8.05 |
Profit & Loss (Figures in Rs. Crores)
Ipca Laboratories Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 3245.02 | 2863.48 | 3174.46 | 3276.05 | 3918.79 | 4862.15 | 5677.62 | 6026.01 | 6269.27 | 8028.46 | |
PROFIT | 249.95 | 88.69 | 191.73 | 234.38 | 438.99 | 596.85 | 1134.03 | 885.33 | 454.16 | 593.55 | |
EPS | 10.27 | 3.81 | 7.71 | 9.49 | 17.5 | 23.89 | 45.29 | 35.91 | 19.39 | 20.86 |
Ipca Laboratories Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 3188.27 | 2809.07 | 3124.59 | 3211.96 | 3766.39 | 4557.56 | 5372.13 | 5617.22 | 5821.72 | 6332.94 | |
PROFIT | 251.84 | 88.89 | 185.45 | 228.18 | 448.61 | 641.6 | 1132.43 | 852.51 | 488.19 | 599.93 | |
EPS | 10.15 | 3.67 | 7.46 | 9.24 | 18 | 25.82 | 44.97 | 33.91 | 19.93 | 20.91 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 25.37 | 25.37 | 25.37 | 25.37 | 25.27 | 25.27 | 25.24 | 25.24 | 25.24 | 25.24 |
Reserves Total | 6,306.82 | 5,816.65 | 5,439.47 | 4,676.28 | 3,590.27 | 3,097.12 | 2,663.33 | 2,430.02 | 2,233.95 | 2,183.19 |
Equity Share Warrants | 0 | 0 | 0 | 0 | 11.94 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 6,332.19 | 5,842.02 | 5,464.84 | 4,701.65 | 3,627.48 | 3,122.39 | 2,688.57 | 2,455.26 | 2,259.19 | 2,208.43 |
Minority Interest | 1,394.81 | 73.3 | 76.92 | 14.53 | 13.63 | 15.54 | 0 | 0 | 0 | 0 |
Secured Loans | 1,209.68 | 857.91 | 554.57 | 140.92 | 324.46 | 444.21 | 622.21 | 656.3 | 738.61 | 759.08 |
Unsecured Loans | 228.68 | 623.36 | 252.65 | 124.47 | 176.26 | 20.74 | 5.35 | 59.45 | 128.57 | 175.91 |
Total Debt | 1,438.36 | 1,481.27 | 807.22 | 265.39 | 500.72 | 464.95 | 627.56 | 715.75 | 867.18 | 934.99 |
Other Liabilities | 87.83 | 47.27 | 44.83 | 40.71 | 34.49 | 26.84 | 27.44 | 26.11 | 21.84 | 22.05 |
Total Liabilities | 9,253.19 | 7,443.86 | 6,393.81 | 5,022.28 | 4,176.32 | 3,629.72 | 3,343.57 | 3,197.12 | 3,148.21 | 3,165.47 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 7,020.79 | 4,364.66 | 3,743.48 | 3,212.19 | 2,985.73 | 2,632.86 | 2,464.33 | 2,318.22 | 2,176.95 | 2,546.33 |
Less: Accumulated Depreciation | 2,467.26 | 1,613.28 | 1,341.29 | 1,139.76 | 927 | 692.48 | 511.37 | 334.95 | 162.77 | 745.9 |
Net Block | 4,553.53 | 2,751.38 | 2,402.19 | 2,072.43 | 2,058.73 | 1,940.38 | 1,952.96 | 1,983.27 | 2,014.18 | 1,800.43 |
Capital Work in Progress | 342.89 | 140.43 | 306.43 | 234.82 | 133.28 | 66.33 | 73 | 94.64 | 128.74 | 267.22 |
Investments | 862.01 | 625.98 | 989.19 | 505.26 | 309.56 | 120.43 | 86.87 | 135.81 | 25.82 | 16.19 |
Inventories | 2,471.31 | 1,743.37 | 1,857.97 | 1,594.81 | 1,323.12 | 1,072.5 | 880.59 | 882.22 | 837.42 | 926.56 |
Sundry Debtors | 1,686.51 | 989.02 | 910.78 | 811.75 | 895.2 | 681.51 | 602.27 | 500.16 | 445.87 | 353 |
Cash and Bank Balance | 296.84 | 1,853.24 | 640.66 | 365.07 | 180.92 | 282.3 | 150.57 | 35.85 | 175.54 | 124.79 |
Loans and Advances | 525.84 | 280.32 | 317.99 | 271.5 | 218.22 | 251.06 | 242.7 | 210.02 | 163.09 | 209.63 |
Total Current Assets | 4,980.5 | 4,865.95 | 3,727.4 | 3,043.13 | 2,617.46 | 2,287.37 | 1,876.13 | 1,628.25 | 1,621.92 | 1,613.98 |
Current Liabilities | 1,249.92 | 862.62 | 945.49 | 797.95 | 840.64 | 684.65 | 535.71 | 526.24 | 520.55 | 436.6 |
Provisions | 287.7 | 130.79 | 119.85 | 114.58 | 101.05 | 88.75 | 78.31 | 65.68 | 66.49 | 35.98 |
Total Current Liabilities & Provisions | 1,537.62 | 993.41 | 1,065.34 | 912.53 | 941.69 | 773.4 | 614.02 | 591.92 | 587.04 | 472.58 |
Net Current Assets | 3,442.88 | 3,872.54 | 2,662.06 | 2,130.6 | 1,675.77 | 1,513.97 | 1,262.11 | 1,036.33 | 1,034.88 | 1,141.4 |
Deferred Tax Assets | 122.82 | 22.25 | 103.53 | 90.39 | 87.51 | 85.26 | 74.49 | 57.91 | 55.65 | 9.57 |
Deferred Tax Liability | 429.06 | 207.84 | 265.89 | 221.99 | 227.32 | 230.97 | 232.46 | 228.38 | 212.11 | 183.88 |
Net Deferred Tax | -306.24 | -185.59 | -162.36 | -131.6 | -139.81 | -145.71 | -157.97 | -170.47 | -156.46 | -174.31 |
Other Assets | 358.12 | 239.12 | 196.3 | 210.77 | 138.79 | 134.32 | 126.6 | 117.54 | 101.05 | 114.54 |
Total Assets | 9,253.19 | 7,443.86 | 6,393.81 | 5,022.28 | 4,176.32 | 3,629.72 | 3,343.57 | 3,197.12 | 3,148.21 | 3,165.47 |
Contingent Liabilities | 129.45 | 152.23 | 69.67 | 55.76 | 42.08 | 40.4 | 43.05 | 45.54 | 47.56 | 255.38 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 25.37 | 25.37 | 25.37 | 25.37 | 25.27 | 25.27 | 25.24 | 25.24 | 25.24 | 25.24 |
Reserves Total | 6,323.34 | 5,851.93 | 5,450.39 | 4,727.35 | 3,640.33 | 3,111.39 | 2,669.71 | 2,449.88 | 2,257.81 | 2,208.09 |
Equity Share Warrants | 0 | 0 | 0 | 0 | 11.94 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 6,348.71 | 5,877.3 | 5,475.76 | 4,752.72 | 3,677.54 | 3,136.66 | 2,694.95 | 2,475.12 | 2,283.05 | 2,233.33 |
Secured Loans | 990.54 | 857.91 | 554.57 | 113.53 | 298.19 | 444.21 | 622.21 | 666.3 | 736.62 | 754.71 |
Unsecured Loans | 161.28 | 582.47 | 221.84 | 122.72 | 176.26 | 0 | 5.35 | 49.45 | 128.58 | 174.1 |
Total Debt | 1,151.82 | 1,440.38 | 776.41 | 236.25 | 474.45 | 444.21 | 627.56 | 715.75 | 865.2 | 928.81 |
Other Liabilities | 50.61 | 46.85 | 44.33 | 39.44 | 33.24 | 26.84 | 27.44 | 26.11 | 21.78 | 20.87 |
Total Liabilities | 7,551.14 | 7,364.53 | 6,296.5 | 5,028.41 | 4,185.23 | 3,607.71 | 3,349.95 | 3,216.98 | 3,170.03 | 3,183.01 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 4,165.82 | 3,889.09 | 3,364.68 | 2,899.27 | 2,688.79 | 2,412.97 | 2,358.72 | 2,276.99 | 2,137.32 | 2,465.9 |
Less : Accumulated Depreciation | 1,642.12 | 1,410.43 | 1,211.59 | 1,030.67 | 847.82 | 672.87 | 504.11 | 331.02 | 160.74 | 712.94 |
Net Block | 2,523.7 | 2,478.66 | 2,153.09 | 1,868.6 | 1,840.97 | 1,740.1 | 1,854.61 | 1,945.97 | 1,976.58 | 1,752.96 |
Capital Work in Progress | 175.2 | 123.02 | 297.15 | 182 | 84.19 | 65.96 | 73.23 | 94.87 | 128.93 | 266.95 |
Investments | 2,654.16 | 1,056.73 | 1,338.7 | 867.84 | 648.72 | 322.24 | 215.63 | 211.58 | 97.43 | 81.86 |
Inventories | 1,677.09 | 1,660.13 | 1,779.54 | 1,517.09 | 1,266.96 | 1,055.55 | 873.17 | 873.54 | 831.93 | 916.98 |
Sundry Debtors | 1,027.4 | 925.9 | 824.3 | 774.46 | 839.13 | 632.06 | 594.38 | 501.98 | 441.45 | 353.55 |
Cash and Bank Balance | 112.92 | 1,706.06 | 595.5 | 306.92 | 152.4 | 259.81 | 131.03 | 17.53 | 161.98 | 113.19 |
Loans and Advances | 281.88 | 259.74 | 305.81 | 285.49 | 215.37 | 247.75 | 239.24 | 205.03 | 164.41 | 209.34 |
Total Current Assets | 3,099.29 | 4,551.83 | 3,505.15 | 2,883.96 | 2,473.86 | 2,195.17 | 1,837.82 | 1,598.08 | 1,599.77 | 1,593.06 |
Current Liabilities | 782.48 | 773.37 | 866.28 | 733.57 | 758.95 | 616.62 | 522.24 | 516.7 | 513.27 | 431.06 |
Provisions | 142.56 | 129.62 | 117.15 | 113.15 | 99.6 | 86.95 | 76.86 | 65.63 | 65.69 | 35.44 |
Total Current Liabilities & Provisions | 925.04 | 902.99 | 983.43 | 846.72 | 858.55 | 703.57 | 599.1 | 582.33 | 578.96 | 466.5 |
Net Current Assets | 2,174.25 | 3,648.84 | 2,521.72 | 2,037.24 | 1,615.31 | 1,491.6 | 1,238.72 | 1,015.75 | 1,020.81 | 1,126.56 |
Deferred Tax Assets | 23.17 | 18.52 | 101.48 | 88.44 | 85.5 | 83.42 | 75.43 | 57.9 | 55.65 | 9.57 |
Deferred Tax Liability | 206.26 | 197.97 | 259.99 | 223.44 | 226.29 | 229.68 | 234.09 | 226.54 | 211.29 | 183.8 |
Net Deferred Tax | -183.09 | -179.45 | -158.51 | -135 | -140.79 | -146.26 | -158.66 | -168.64 | -155.64 | -174.23 |
Other Assets | 206.92 | 236.73 | 144.35 | 207.73 | 136.83 | 134.07 | 126.42 | 117.45 | 101.92 | 128.91 |
Total Assets | 7,551.14 | 7,364.53 | 6,296.5 | 5,028.41 | 4,185.23 | 3,607.71 | 3,349.95 | 3,216.98 | 3,170.03 | 3,183.01 |
Contingent Liabilities | 124.51 | 1,996.35 | 103.39 | 86.68 | 64.78 | 40.4 | 43.05 | 45.47 | 49.55 | 259.76 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 842.67 |
Depreciation | 357.24 |
Interest (Net) | 75.34 |
P/L on Sales of Assets | -3.49 |
P/L on Sales of Invest | -64.78 |
Prov. and W/O (Net) | 139.96 |
P/L in Forex | -7.2 |
Total Adjustments (PBT and Ext... | 489.87 |
Operating Profit before Workin... | 1,332.54 |
Trade and 0ther Receivables | -75.8 |
Inventories | -94.7 |
Trade Payables | 21.49 |
Total Adjustments (OP before W... | -91.59 |
Cash Generated from/(used in) ... | 1,240.95 |
Direct Taxes Paid | -296.3 |
Total Adjustments(Cash Generat... | -296.3 |
Cash Flow before Extraordinary... | 944.65 |
Net Cash from Operating Activi... | 944.65 |
Purchased of Fixed Assets | -410.6 |
Sale of Fixed Assets | 8.62 |
Sale of Investments | 64.78 |
Interest Received | 80.88 |
Investment in Group Cos. | -25.11 |
Net Cash used in Investing Act... | -1,215.29 |
Proceed from 0ther Long Term B... | 123.71 |
Of the Long Tem Borrowings | -176.76 |
Of the Short Term Borrowings | -303.83 |
Of Financial Liabilities | -10.68 |
Dividend Paid | -50.74 |
Interest Paid | -134.25 |
Net Cash used in Financing Act... | -552.55 |
Net Profit before Tax and Extr... | 822.16 |
Depreciation | 246.48 |
Interest (Net) | 64.91 |
P/L on Sales of Assets | 1.95 |
Prov. and W/O (Net) | 94.33 |
P/L in Forex | -7.11 |
Total Adjustments (PBT and Ext... | 399.16 |
Operating Profit before Workin... | 1,221.32 |
Trade and 0ther Receivables | -102 |
Inventories | -16.96 |
Trade Payables | -28.51 |
Total Adjustments (OP before W... | -113.86 |
Cash Generated from/(used in) ... | 1,107.46 |
Direct Taxes Paid | -276.95 |
Total Adjustments(Cash Generat... | -276.95 |
Cash Flow before Extraordinary... | 830.51 |
Net Cash from Operating Activi... | 830.51 |
Purchased of Fixed Assets | -360.22 |
Sale of Fixed Assets | 3.75 |
Interest Received | 72.54 |
Invest.In Subsidiaires | -1,586.17 |
Investment in Group Cos. | -25.11 |
Net Cash used in Investing Act... | -1,355.18 |
Proceed from 0ther Long Term B... | 123.71 |
Of the Long Tem Borrowings | -157.68 |
Of the Short Term Borrowings | -258.88 |
Of Financial Liabilities | -4.54 |
Dividend Paid | -50.74 |
Interest Paid | -116.75 |
Net Cash used in Financing Act... | -464.88 |
Company Details
Registered Office |
|
Address | 48 Kandivli Industrial Estate, Kandivli (West) |
City | Mumbai |
State | Maharashtra |
Pin Code | 400067 |
Tel. No. | 91-22-66474444 |
Fax. No. | 91-22-28686613 |
investors@ipca.com ; ipca@ipca.com | |
Internet | http://www.ipca.com |
Registrars |
|
Address | 48 Kandivli Industrial Estate |
City | Mumbai |
State | Maharashtra |
Pin Code | 400067 |
Tel. No. | 91-22-66474444 |
Fax. No. | 91-22-28686613 |
investors@ipca.com ; ipca@ipca.com | |
Internet | http://www.ipca.com |
Management |
|
Name | Designation |
Premchand Godha | Executive Chairman |
A K Jain | Managing Director & CFO |
Pranay Godha | Managing Director & CEO |
Prashant Godha | Executive Director |
Kamal Kishore Seth | Independent Non Exe. Director |
Narendra Mairpady | Independent Non Exe. Director |
Harish P Kamath | Company Sec. & Compli. Officer |
Swati Patankar | Independent Director |
Vivek Shiralkar | Independent Director |